14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 IDYA stock ended at $43.09. This is 2.16% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 3.63% from a day low at $41.78 to a day high of $43.29.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical IDEAYA Biosciences Inc. prices

Date Open High Low Close Volume
May 06, 2024 $42.32 $43.29 $41.78 $43.09 422 886
May 03, 2024 $42.27 $43.00 $42.00 $42.18 346 253
May 02, 2024 $41.86 $42.04 $40.91 $41.49 473 017
May 01, 2024 $40.81 $42.45 $40.46 $41.18 1 116 341
Apr 30, 2024 $40.47 $41.22 $39.98 $40.65 705 960
Apr 29, 2024 $39.98 $41.38 $39.98 $40.65 617 750
Apr 26, 2024 $38.90 $40.33 $38.17 $39.94 607 109
Apr 25, 2024 $39.06 $39.89 $37.81 $38.62 715 308
Apr 24, 2024 $39.13 $40.31 $38.96 $39.85 1 297 536
Apr 23, 2024 $38.00 $39.53 $38.00 $39.02 486 098
Apr 22, 2024 $37.61 $38.52 $36.85 $37.59 773 950
Apr 19, 2024 $37.38 $38.30 $36.58 $37.13 704 849
Apr 18, 2024 $39.97 $40.17 $37.51 $37.62 792 559
Apr 17, 2024 $41.40 $41.45 $39.81 $40.17 467 800
Apr 16, 2024 $41.36 $42.02 $41.05 $41.17 387 907
Apr 15, 2024 $41.92 $42.68 $40.97 $41.51 311 344
Apr 12, 2024 $43.30 $43.84 $41.29 $41.97 384 905
Apr 11, 2024 $42.67 $43.60 $42.36 $43.46 497 237
Apr 10, 2024 $41.34 $42.42 $41.10 $42.30 513 426
Apr 09, 2024 $42.11 $42.71 $41.70 $42.57 564 766
Apr 08, 2024 $43.02 $43.03 $41.43 $41.99 465 460
Apr 05, 2024 $41.37 $42.65 $40.70 $42.51 376 726
Apr 04, 2024 $42.43 $42.87 $41.22 $41.40 395 393
Apr 03, 2024 $40.97 $42.16 $40.95 $42.15 462 479
Apr 02, 2024 $42.00 $42.72 $41.35 $41.50 634 722
Click to get the best stock tips daily for free!

About IDEAYA Biosciences Inc.

IDEAYA Biosciences. IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, ... IDYA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT